Pharmacology & ToxicologybioRxivPreprint
Development of allosteric, selective cyclin-dependent kinase 2 (CDK2) inhibitors that are negatively cooperative with cyclin binding and show potential as contraceptive agents
E. B. Faber, J. Tang, E. Roberts…·G. I. Georg
This paper develops high-affinity, structurally confirmed allosteric CDK2 inhibitors that show negative cooperativity with cyclin binding and demonstrate contraceptive potential in mouse testicular explants.
DOI 10.1101/2022.06.30.497818